カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗てんかん薬の世界市場見通し2023年-2029年

◆英語タイトル：Anti Epilepsy Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5662）◆商品コード：MMG23JU5662
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：71
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti Epilepsy Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの抗てんかん薬市場規模と予測を収録しています。・世界の抗てんかん薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗てんかん薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗てんかん薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「第一世代AED」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗てんかん薬のグローバル主要企業は、Abbott Laboratories、 Cephalon、 Sunovion Pharmaceuticals、 Bausch Health、 Sanofi、 UCB Pharma、 GlaxoSmithKline、 Johnson & Johnson、 Novartis、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗てんかん薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗てんかん薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗てんかん薬市場：タイプ別市場シェア、2022年
・第一世代AED、第二世代AED

世界の抗てんかん薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗てんかん薬市場：用途別市場シェア、2022年
・焦点発作、全般発作

世界の抗てんかん薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗てんかん薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗てんかん薬のグローバル売上、2018年-2023年
・主要企業における抗てんかん薬のグローバル売上シェア、2022年
・主要企業における抗てんかん薬のグローバル販売量、2018年-2023年
・主要企業における抗てんかん薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott Laboratories、 Cephalon、 Sunovion Pharmaceuticals、 Bausch Health、 Sanofi、 UCB Pharma、 GlaxoSmithKline、 Johnson & Johnson、 Novartis、 Pfizer

*************************************************************

・調査・分析レポートの概要
抗てんかん薬市場の定義
市場セグメント
世界の抗てんかん薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗てんかん薬市場規模
世界の抗てんかん薬市場規模：2022年 VS 2029年
世界の抗てんかん薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗てんかん薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗てんかん薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：第一世代AED、第二世代AED
抗てんかん薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：焦点発作、全般発作
抗てんかん薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗てんかん薬市場規模 2022年と2029年
地域別抗てんかん薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott Laboratories、 Cephalon、 Sunovion Pharmaceuticals、 Bausch Health、 Sanofi、 UCB Pharma、 GlaxoSmithKline、 Johnson & Johnson、 Novartis、 Pfizer
...

Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to wrong signal sent by nerve cells to the brain. Antiepileptic drugs also act as mood stabilizers and also used in the treatment of bipolar disorders or neuropathic pain.
This report aims to provide a comprehensive presentation of the global market for Anti Epilepsy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Epilepsy Drugs. This report contains market size and forecasts of Anti Epilepsy Drugs in global, including the following market information:
Global Anti Epilepsy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti Epilepsy Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti Epilepsy Drugs companies in 2022 (%)
The global Anti Epilepsy Drugs market was valued at US$ 3593.1 million in 2022 and is projected to reach US$ 4130.1 million by 2029, at a CAGR of 2.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
First Generation AEDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti Epilepsy Drugs include Abbott Laboratories, Cephalon, Sunovion Pharmaceuticals, Bausch Health, Sanofi, UCB Pharma, GlaxoSmithKline, Johnson & Johnson and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti Epilepsy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Epilepsy Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Epilepsy Drugs Market Segment Percentages, by Type, 2022 (%)
First Generation AEDs
Second Generation AEDs
Global Anti Epilepsy Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Epilepsy Drugs Market Segment Percentages, by Application, 2022 (%)
Partial
Generalized
Global Anti Epilepsy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Epilepsy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Epilepsy Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti Epilepsy Drugs revenues share in global market, 2022 (%)
Key companies Anti Epilepsy Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti Epilepsy Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Cephalon
Sunovion Pharmaceuticals
Bausch Health
Sanofi
UCB Pharma
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti Epilepsy Drugs, market overview.
Chapter 2: Global Anti Epilepsy Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti Epilepsy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti Epilepsy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti Epilepsy Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti Epilepsy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti Epilepsy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti Epilepsy Drugs Overall Market Size
2.1 Global Anti Epilepsy Drugs Market Size: 2022 VS 2029
2.2 Global Anti Epilepsy Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti Epilepsy Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti Epilepsy Drugs Players in Global Market
3.2 Top Global Anti Epilepsy Drugs Companies Ranked by Revenue
3.3 Global Anti Epilepsy Drugs Revenue by Companies
3.4 Global Anti Epilepsy Drugs Sales by Companies
3.5 Global Anti Epilepsy Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti Epilepsy Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti Epilepsy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti Epilepsy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti Epilepsy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti Epilepsy Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti Epilepsy Drugs Market Size Markets, 2022 & 2029
4.1.2 First Generation AEDs
4.1.3 Second Generation AEDs
4.2 By Type – Global Anti Epilepsy Drugs Revenue & Forecasts
4.2.1 By Type – Global Anti Epilepsy Drugs Revenue, 2018-2023
4.2.2 By Type – Global Anti Epilepsy Drugs Revenue, 2024-2029
4.2.3 By Type – Global Anti Epilepsy Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Anti Epilepsy Drugs Sales & Forecasts
4.3.1 By Type – Global Anti Epilepsy Drugs Sales, 2018-2023
4.3.2 By Type – Global Anti Epilepsy Drugs Sales, 2024-2029
4.3.3 By Type – Global Anti Epilepsy Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Anti Epilepsy Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti Epilepsy Drugs Market Size, 2022 & 2029
5.1.2 Partial
5.1.3 Generalized
5.2 By Application – Global Anti Epilepsy Drugs Revenue & Forecasts
5.2.1 By Application – Global Anti Epilepsy Drugs Revenue, 2018-2023
5.2.2 By Application – Global Anti Epilepsy Drugs Revenue, 2024-2029
5.2.3 By Application – Global Anti Epilepsy Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Anti Epilepsy Drugs Sales & Forecasts
5.3.1 By Application – Global Anti Epilepsy Drugs Sales, 2018-2023
5.3.2 By Application – Global Anti Epilepsy Drugs Sales, 2024-2029
5.3.3 By Application – Global Anti Epilepsy Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Anti Epilepsy Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti Epilepsy Drugs Market Size, 2022 & 2029
6.2 By Region – Global Anti Epilepsy Drugs Revenue & Forecasts
6.2.1 By Region – Global Anti Epilepsy Drugs Revenue, 2018-2023
6.2.2 By Region – Global Anti Epilepsy Drugs Revenue, 2024-2029
6.2.3 By Region – Global Anti Epilepsy Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Anti Epilepsy Drugs Sales & Forecasts
6.3.1 By Region – Global Anti Epilepsy Drugs Sales, 2018-2023
6.3.2 By Region – Global Anti Epilepsy Drugs Sales, 2024-2029
6.3.3 By Region – Global Anti Epilepsy Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti Epilepsy Drugs Revenue, 2018-2029
6.4.2 By Country – North America Anti Epilepsy Drugs Sales, 2018-2029
6.4.3 US Anti Epilepsy Drugs Market Size, 2018-2029
6.4.4 Canada Anti Epilepsy Drugs Market Size, 2018-2029
6.4.5 Mexico Anti Epilepsy Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti Epilepsy Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Anti Epilepsy Drugs Sales, 2018-2029
6.5.3 Germany Anti Epilepsy Drugs Market Size, 2018-2029
6.5.4 France Anti Epilepsy Drugs Market Size, 2018-2029
6.5.5 U.K. Anti Epilepsy Drugs Market Size, 2018-2029
6.5.6 Italy Anti Epilepsy Drugs Market Size, 2018-2029
6.5.7 Russia Anti Epilepsy Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti Epilepsy Drugs Market Size, 2018-2029
6.5.9 Benelux Anti Epilepsy Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti Epilepsy Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Anti Epilepsy Drugs Sales, 2018-2029
6.6.3 China Anti Epilepsy Drugs Market Size, 2018-2029
6.6.4 Japan Anti Epilepsy Drugs Market Size, 2018-2029
6.6.5 South Korea Anti Epilepsy Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti Epilepsy Drugs Market Size, 2018-2029
6.6.7 India Anti Epilepsy Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti Epilepsy Drugs Revenue, 2018-2029
6.7.2 By Country – South America Anti Epilepsy Drugs Sales, 2018-2029
6.7.3 Brazil Anti Epilepsy Drugs Market Size, 2018-2029
6.7.4 Argentina Anti Epilepsy Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti Epilepsy Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti Epilepsy Drugs Sales, 2018-2029
6.8.3 Turkey Anti Epilepsy Drugs Market Size, 2018-2029
6.8.4 Israel Anti Epilepsy Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti Epilepsy Drugs Market Size, 2018-2029
6.8.6 UAE Anti Epilepsy Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Anti Epilepsy Drugs Major Product Offerings
7.1.4 Abbott Laboratories Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Cephalon
7.2.1 Cephalon Company Summary
7.2.2 Cephalon Business Overview
7.2.3 Cephalon Anti Epilepsy Drugs Major Product Offerings
7.2.4 Cephalon Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Cephalon Key News & Latest Developments
7.3 Sunovion Pharmaceuticals
7.3.1 Sunovion Pharmaceuticals Company Summary
7.3.2 Sunovion Pharmaceuticals Business Overview
7.3.3 Sunovion Pharmaceuticals Anti Epilepsy Drugs Major Product Offerings
7.3.4 Sunovion Pharmaceuticals Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sunovion Pharmaceuticals Key News & Latest Developments
7.4 Bausch Health
7.4.1 Bausch Health Company Summary
7.4.2 Bausch Health Business Overview
7.4.3 Bausch Health Anti Epilepsy Drugs Major Product Offerings
7.4.4 Bausch Health Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Bausch Health Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Anti Epilepsy Drugs Major Product Offerings
7.5.4 Sanofi Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 UCB Pharma
7.6.1 UCB Pharma Company Summary
7.6.2 UCB Pharma Business Overview
7.6.3 UCB Pharma Anti Epilepsy Drugs Major Product Offerings
7.6.4 UCB Pharma Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.6.5 UCB Pharma Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Anti Epilepsy Drugs Major Product Offerings
7.7.4 GlaxoSmithKline Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Anti Epilepsy Drugs Major Product Offerings
7.8.4 Johnson & Johnson Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Anti Epilepsy Drugs Major Product Offerings
7.9.4 Novartis Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Anti Epilepsy Drugs Major Product Offerings
7.10.4 Pfizer Anti Epilepsy Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
8 Global Anti Epilepsy Drugs Production Capacity, Analysis
8.1 Global Anti Epilepsy Drugs Production Capacity, 2018-2029
8.2 Anti Epilepsy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti Epilepsy Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti Epilepsy Drugs Supply Chain Analysis
10.1 Anti Epilepsy Drugs Industry Value Chain
10.2 Anti Epilepsy Drugs Upstream Market
10.3 Anti Epilepsy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti Epilepsy Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anti Epilepsy Drugs in Global Market
Table 2. Top Anti Epilepsy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti Epilepsy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti Epilepsy Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti Epilepsy Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti Epilepsy Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti Epilepsy Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti Epilepsy Drugs Product Type
Table 9. List of Global Tier 1 Anti Epilepsy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti Epilepsy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti Epilepsy Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti Epilepsy Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti Epilepsy Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti Epilepsy Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Anti Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti Epilepsy Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti Epilepsy Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti Epilepsy Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti Epilepsy Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Anti Epilepsy Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti Epilepsy Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti Epilepsy Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti Epilepsy Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti Epilepsy Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti Epilepsy Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti Epilepsy Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti Epilepsy Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti Epilepsy Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti Epilepsy Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti Epilepsy Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti Epilepsy Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti Epilepsy Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti Epilepsy Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti Epilepsy Drugs Sales, (K Units), 2024-2029
Table 46. Abbott Laboratories Company Summary
Table 47. Abbott Laboratories Anti Epilepsy Drugs Product Offerings
Table 48. Abbott Laboratories Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Abbott Laboratories Key News & Latest Developments
Table 50. Cephalon Company Summary
Table 51. Cephalon Anti Epilepsy Drugs Product Offerings
Table 52. Cephalon Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Cephalon Key News & Latest Developments
Table 54. Sunovion Pharmaceuticals Company Summary
Table 55. Sunovion Pharmaceuticals Anti Epilepsy Drugs Product Offerings
Table 56. Sunovion Pharmaceuticals Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sunovion Pharmaceuticals Key News & Latest Developments
Table 58. Bausch Health Company Summary
Table 59. Bausch Health Anti Epilepsy Drugs Product Offerings
Table 60. Bausch Health Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bausch Health Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Anti Epilepsy Drugs Product Offerings
Table 64. Sanofi Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. UCB Pharma Company Summary
Table 67. UCB Pharma Anti Epilepsy Drugs Product Offerings
Table 68. UCB Pharma Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. UCB Pharma Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Anti Epilepsy Drugs Product Offerings
Table 72. GlaxoSmithKline Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Anti Epilepsy Drugs Product Offerings
Table 76. Johnson & Johnson Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Anti Epilepsy Drugs Product Offerings
Table 80. Novartis Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Anti Epilepsy Drugs Product Offerings
Table 84. Pfizer Anti Epilepsy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Anti Epilepsy Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Anti Epilepsy Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Anti Epilepsy Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Anti Epilepsy Drugs Production by Region, 2024-2029 (K Units)
Table 90. Anti Epilepsy Drugs Market Opportunities & Trends in Global Market
Table 91. Anti Epilepsy Drugs Market Drivers in Global Market
Table 92. Anti Epilepsy Drugs Market Restraints in Global Market
Table 93. Anti Epilepsy Drugs Raw Materials
Table 94. Anti Epilepsy Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Anti Epilepsy Drugs Downstream
Table 96. Anti Epilepsy Drugs Downstream Clients in Global Market
Table 97. Anti Epilepsy Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti Epilepsy Drugs Segment by Type in 2022
Figure 2. Anti Epilepsy Drugs Segment by Application in 2022
Figure 3. Global Anti Epilepsy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti Epilepsy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti Epilepsy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti Epilepsy Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti Epilepsy Drugs Revenue in 2022
Figure 9. By Type - Global Anti Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti Epilepsy Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti Epilepsy Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti Epilepsy Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 23. US Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 37. China Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti Epilepsy Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti Epilepsy Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti Epilepsy Drugs by Region, 2022 VS 2029
Figure 54. Anti Epilepsy Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 抗てんかん薬の世界市場見通し2023年-2029年(Anti Epilepsy Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 抗てんかん薬の世界市場2023年～2030年：薬剤別、流通チャネル別、地域別
  • 腫瘍学（抗がん剤）の世界市場見通し2023年-2029年
  • 抗老化薬の世界市場見通し2023年-2029年
  • 抗統合失調症薬の世界市場見通し2023年-2029年
  • 抗うつ剤の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆